Austerity for the Many, “Investments” for the Few? What to expect in the November 4 federal budgetOctober 30, 2025October 30, 2025by Nikolas Barry-ShawAnalysis
On the Frontline for Pharmacare in EdmontonSeptember 13, 2025September 14, 2025by Nikolas Barry-ShawAnalysis, Campaign
Snap out of denial—Mark Carney’s rightward-rushing agenda is just getting startedJuly 17, 2025July 17, 2025by Nikolas Barry-ShawAnalysis
Trump’s Golden Dome turbocharges the war machine—and Carney wants us to pay for itJune 9, 2025June 11, 2025by Nikolas Barry-ShawAnalysis
Catching our breath: Looking ahead after the electionMay 2, 2025May 2, 2025by Nikolas Barry-ShawAnalysis
Pierre Poilievre’s Conservatives Rev Up their Chainsaw April 28, 2025April 29, 2025by Nikolas Barry-ShawAnalysis
Trump, Poilievre, Carney and the Corporate Agenda: An Update to Our Election PrimerMarch 25, 2025April 14, 2025by Nikolas Barry-ShawAnalysis
Canada’s CEOs want to cash in on Trump’s tariff threatsFebruary 11, 2025February 14, 2025by Nikolas Barry-ShawAnalysis
After prorogation, pharmacare hangs in the balanceJanuary 17, 2025January 17, 2025by Nikolas Barry-ShawAnalysis
Donald Trump says jump, Canada’s corporate elite ask how high December 12, 2024December 12, 2024by Nikolas Barry-ShawAnalysis
